Global Endometriosis Market to Reach US$ 3.7 Billion by 2032, Propelled by Rising Prevalence of Endometriosis

March 27, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Endometriosis Market by Type (Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End Users (Hospitals, Homecare, Speciality Centers, and Others), and Region 2024-2032," the global endometriosis market size reached US$ 2.4 Billion in 2023. Endometriosis refers to a medical condition that causes excessive growth of endometrial tissues in various regions outside the uterus, such as the fallopian tube, uterine cavity, and ovaries. Chronic pelvic pain, fatigue, bloating, constipation, infertility, and discomfort during urination are some of the common symptoms. It is diagnosed through physical examinations of the pelvic region and various imaging tests, such as ultrasound and magnetic resonance imaging (MRI). Endometriosis is treated using over-the-counter medications, fertility treatments, hormonal therapy, and surgical procedures. These treatments aid in alleviating pain, increasing the chance of pregnancy, minimizing complications, improving the overall quality of life, and managing various symptoms, such as inflammation, nausea, and scarring.

Global Endometriosis Market Trends:

The rising prevalence of endometriosis due to genetics, hormonal imbalance, retrograde mensuration, immune system dysfunction, and environmental toxins is one of the primary factors driving the market growth. In addition to this, the increasing awareness among the masses regarding early diagnosis of endometriosis to prevent various complications, such as ovarian cysts, adhesion, and bladder dysfunction, is acting as another growth-inducing factor. Furthermore, rising demand for minimally invasive (MI) surgical procedures, such as laparoscopy, which reduces pain and scarring, promote faster recovery, and minimize the risk of infections, blood loss, and surgical complications, is providing an impetus to the market growth. Additionally, the recent development of non-surgical treatment options, such as ultrasound therapy which utilizes high-intensity focused ultrasound (HIFU) to destroy endometrial tissues at high precision and eliminate the need for medications and hormonal treatments, is positively influencing the market growth. Moreover, growing initiatives by several governments and international organizations, such as the Endometriosis Association and World Endometrial Society, to increase awareness and improve access to care for women are creating a positive outlook for market growth. Other factors, including rising healthcare expenditure, rapid advancements in diagnostic techniques, and increasing investment in the research and development (R&D) of novel treatment methods, are anticipated to drive the market growth. On account of the aforementioned factors, the market value is expected to reach US$ 3.7 Billion by 2032, exhibiting a CAGR of 4.71% during 2024-2032.

Market Summary:

  • On the basis of type, the market has been divided into superficial peritoneal lesion, endometrioma, deeply infiltrating endometriosis, and others.
  • Based on the diagnosis and treatment, the market has been classified into diagnosis (ultrasound, pelvic exam, laparoscopy, magnetic resonance imaging (MRI), hysteroscopy, and sonohysterography) and treatment (hormonal therapy, pain management, and conservative surgery).
  • On the basis of end users, the market has been divided into hospitals, homecare, specialty centers, and others. At present, hospitals accounted for the largest market share.
  • On a regional basis, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and Others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and Others), Latin America (Brazil, Mexico, and Others), and Middle East and Africa. Among these, North America is the leading market.
  • The competitive landscape of the industry has also been examined, with some of the key players being Abbott Laboratories, AbbVie Inc., Bayer AG, Debiopharm Group, Gedeon Richter Plc, Kissei Pharmaceutical Co. Ltd., Myovant Sciences GmbH, Sanofi S.A., Teva Pharmaceutical Industries Ltd., etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Type, Diagnosis and Treatment, End Users, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, AbbVie Inc., Bayer AG, Debiopharm Group, Gedeon Richter Plc, Kissei Pharmaceutical Co. Ltd., Myovant Sciences GmbH, Sanofi S.A., Teva Pharmaceutical Industries Ltd., etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N A
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Endometriosis Market to Reach US$ 3.7 Billion by 2032, Propelled by Rising Prevalence of Endometriosis
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More